Rehmann Capital Advisory Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$122K Sell
3,636
-133
-4% -$4.71K 0.01% 405
2019
Q2
$148K Buy
3,769
+1,204
+47% +$47.7K 0.02% 497
2019
Q1
$104K Buy
2,565
+817
+47% +$30.5K 0.01% 582
2018
Q4
$56.6K Buy
1,748
+438
+33% +$17.7K 0.01% 556
2018
Q3
$67.4K Sell
1,310
-393
-23% -$19.7K 0.01% 701
2018
Q2
$85.7K Buy
1,703
+1,081
+174% +$54.8K 0.01% 595
2018
Q1
$32K Buy
+622
New +$33.2K 0.01% 910

Other funds holding FMS

Rehmann Capital Advisory Group's FMS Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Fresenius Medical Care (FMS) stake by 3.5% in Q3 2019, selling an estimated $4.71K and leaving 3,636 shares worth $122K. The position accounts for 0.01% of the portfolio, ranked #405.

Rehmann Capital Advisory Group first reported a position in FMS in Q1 2018 and has held it in 7 quarters since. The position peaked at $148K in Q2 2019. 161 funds tracked by Wall St. Rank hold FMS as of Q3 2019.

  • Rehmann Capital Advisory Group held 3,636 shares of Fresenius Medical Care worth $122K as of Q3 2019.
  • Rehmann Capital Advisory Group sold 133 Fresenius Medical Care shares in Q3 2019, an estimated $4.71K.
  • Fresenius Medical Care made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #405 holding.
  • Rehmann Capital Advisory Group first reported a position in Fresenius Medical Care in Q1 2018 and has held it in 7 quarters since.
  • Rehmann Capital Advisory Group's Fresenius Medical Care position peaked at $148K in Q2 2019.
  • 161 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.